JP2005102701A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2005102701A5 JP2005102701A5 JP2004338711A JP2004338711A JP2005102701A5 JP 2005102701 A5 JP2005102701 A5 JP 2005102701A5 JP 2004338711 A JP2004338711 A JP 2004338711A JP 2004338711 A JP2004338711 A JP 2004338711A JP 2005102701 A5 JP2005102701 A5 JP 2005102701A5
- Authority
- JP
- Japan
- Prior art keywords
- amino acid
- pharmaceutical composition
- antigenic
- acid residues
- ige
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 230000000890 antigenic effect Effects 0.000 claims 11
- 239000008194 pharmaceutical composition Substances 0.000 claims 7
- 108090000765 processed proteins & peptides Proteins 0.000 claims 7
- 125000000539 amino acid group Chemical group 0.000 claims 6
- 230000000172 allergic effect Effects 0.000 claims 5
- 208000010668 atopic eczema Diseases 0.000 claims 5
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 claims 5
- 102000037865 fusion proteins Human genes 0.000 claims 5
- 108020001507 fusion proteins Proteins 0.000 claims 5
- 230000001404 mediated effect Effects 0.000 claims 5
- 102000040430 polynucleotide Human genes 0.000 claims 5
- 108091033319 polynucleotide Proteins 0.000 claims 5
- 239000002157 polynucleotide Substances 0.000 claims 5
- 230000002265 prevention Effects 0.000 claims 4
- 238000004519 manufacturing process Methods 0.000 claims 3
- 239000003937 drug carrier Substances 0.000 claims 2
- 239000012634 fragment Substances 0.000 claims 2
- 238000000034 method Methods 0.000 claims 2
- 102000014914 Carrier Proteins Human genes 0.000 claims 1
- 108010078791 Carrier Proteins Proteins 0.000 claims 1
- 206010010741 Conjunctivitis Diseases 0.000 claims 1
- 206010014950 Eosinophilia Diseases 0.000 claims 1
- 208000004262 Food Hypersensitivity Diseases 0.000 claims 1
- 206010016946 Food allergy Diseases 0.000 claims 1
- 206010018364 Glomerulonephritis Diseases 0.000 claims 1
- 208000009329 Graft vs Host Disease Diseases 0.000 claims 1
- 206010039085 Rhinitis allergic Diseases 0.000 claims 1
- 239000002671 adjuvant Substances 0.000 claims 1
- 201000010105 allergic rhinitis Diseases 0.000 claims 1
- 125000003275 alpha amino acid group Chemical group 0.000 claims 1
- 208000006673 asthma Diseases 0.000 claims 1
- 239000003814 drug Substances 0.000 claims 1
- 239000013604 expression vector Substances 0.000 claims 1
- 235000020932 food allergy Nutrition 0.000 claims 1
- 201000005298 gastrointestinal allergy Diseases 0.000 claims 1
- 208000024908 graft versus host disease Diseases 0.000 claims 1
- 102000004196 processed proteins & peptides Human genes 0.000 claims 1
- 102000004169 proteins and genes Human genes 0.000 claims 1
- 108090000623 proteins and genes Proteins 0.000 claims 1
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US22898900P | 2000-08-30 | 2000-08-30 |
Related Parent Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2001261760A Division JP2002281984A (ja) | 2000-08-30 | 2001-08-30 | 抗ＩｇＥワクチン |
Related Child Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2012080895A Division JP2012161322A (ja) | 2000-08-30 | 2012-03-30 | 抗ＩｇＥワクチン |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2005102701A JP2005102701A (ja) | 2005-04-21 |
| JP2005102701A5 true JP2005102701A5 (enExample) | 2011-04-21 |
Family
ID=22859366
Family Applications (5)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2001261760A Pending JP2002281984A (ja) | 2000-08-30 | 2001-08-30 | 抗ＩｇＥワクチン |
| JP2004244935A Pending JP2005043374A (ja) | 2000-08-30 | 2004-08-25 | 抗ＩｇＥワクチン |
| JP2004338711A Pending JP2005102701A (ja) | 2000-08-30 | 2004-11-24 | 抗ＩｇＥワクチン |
| JP2012080895A Pending JP2012161322A (ja) | 2000-08-30 | 2012-03-30 | 抗ＩｇＥワクチン |
| JP2012232974A Pending JP2013056904A (ja) | 2000-08-30 | 2012-10-22 | 抗ＩｇＥワクチン |
Family Applications Before (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2001261760A Pending JP2002281984A (ja) | 2000-08-30 | 2001-08-30 | 抗ＩｇＥワクチン |
| JP2004244935A Pending JP2005043374A (ja) | 2000-08-30 | 2004-08-25 | 抗ＩｇＥワクチン |
Family Applications After (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2012080895A Pending JP2012161322A (ja) | 2000-08-30 | 2012-03-30 | 抗ＩｇＥワクチン |
| JP2012232974A Pending JP2013056904A (ja) | 2000-08-30 | 2012-10-22 | 抗ＩｇＥワクチン |
Country Status (4)
| Country | Link |
|---|---|
| US (5) | US6887472B2 (enExample) |
| EP (5) | EP1195161A3 (enExample) |
| JP (5) | JP2002281984A (enExample) |
| CA (5) | CA2674837C (enExample) |
Families Citing this family (29)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP1195161A3 (en) * | 2000-08-30 | 2002-07-24 | Pfizer Products Inc. | Anti-IgE vaccines |
| EP2687593A1 (en) * | 2001-05-15 | 2014-01-22 | Ortho-McNeil Pharmaceutical, Inc. | Ex-vivo priming for generating cytotoxic T lymphocytes specific for non-tumor antigens to treat autoimmune and allergic disease |
| JP2003047482A (ja) * | 2001-05-22 | 2003-02-18 | Pfizer Prod Inc | 非アナフィラキシー誘発性ＩｇＥワクチン |
| ATE414540T1 (de) * | 2002-09-05 | 2008-12-15 | Resistentia Pharmaceuticals Ab | Impfstoffe gegen allergien |
| US20070178082A1 (en) * | 2002-11-08 | 2007-08-02 | Ablynx N.V. | Stabilized single domain antibodies |
| US9320792B2 (en) | 2002-11-08 | 2016-04-26 | Ablynx N.V. | Pulmonary administration of immunoglobulin single variable domains and constructs thereof |
| US20100003253A1 (en) * | 2002-11-08 | 2010-01-07 | Ablynx N.V. | Single domain antibodies directed against epidermal growth factor receptor and uses therefor |
| WO2004041862A2 (en) * | 2002-11-08 | 2004-05-21 | Ablynx N.V. | Single domain antibodies directed against tumour necrosis factor-alpha and uses therefor |
| US20060034845A1 (en) * | 2002-11-08 | 2006-02-16 | Karen Silence | Single domain antibodies directed against tumor necrosis factor alpha and uses therefor |
| KR20070008578A (ko) | 2004-02-02 | 2007-01-17 | 타녹스 인코퍼레이티드 | 신규한 ＩｇＥ 에피토프의 확인 |
| JP4520923B2 (ja) * | 2005-09-28 | 2010-08-11 | 本田技研工業株式会社 | エンジン始動装置 |
| JP2007172129A (ja) * | 2005-12-20 | 2007-07-05 | Sony Corp | 不揮発性メモリアクセス制御装置および不揮発性メモリ制御システム |
| AU2013204233B2 (en) * | 2008-12-09 | 2015-06-25 | Pfizer Vaccines Llc | IgE CH3 peptide vaccine |
| PE20110891A1 (es) * | 2008-12-09 | 2011-12-23 | Pfizer Vaccines Llc | Vacuna de peptido ch3 de ige |
| RU2015109110A (ru) * | 2009-02-25 | 2015-07-20 | Академиа Синика | Применение семх пептидов для индукции иммунного ответа на мембрансвязанный ige (mige) на человеческих в лимфоцитах |
| EP2575868A1 (en) | 2010-06-07 | 2013-04-10 | Pfizer Vaccines LLC | Ige ch3 peptide vaccine |
| KR101163472B1 (ko) * | 2010-06-08 | 2012-07-18 | 기아자동차주식회사 | 자동차의 오프닝 웨더스트립 고정구조 |
| US9187553B2 (en) * | 2012-01-25 | 2015-11-17 | Swey-Shen Chen | Displaying native human IgE neutralizing FcepsilonRIa-contacting IgE B-cell epitopes by constraining super beta(b)-strands and cystine knots on thermostable protein scaffold |
| CN104603150A (zh) | 2012-04-20 | 2015-05-06 | 中央研究院 | 与CH4和CεmX结构域之间的连接处结合的抗mIgE抗体 |
| CN102660569B (zh) * | 2012-04-21 | 2013-11-06 | 大连理工大学 | 一种重组人IgE受体蛋白的制备方法及应用 |
| EP2862873B1 (en) * | 2012-06-18 | 2020-04-29 | Nippon Zenyaku Kogyo Co., Ltd. | IgE PEPTIDE VACCINE |
| US10428112B2 (en) | 2014-06-11 | 2019-10-01 | Riken | Multiplexed same type-antigenic peptide |
| CA2982213C (en) * | 2015-04-09 | 2022-10-18 | Cornell University | Gene therapy to prevent reactions to allergens |
| IL277911B2 (en) | 2017-10-31 | 2025-07-01 | Oneness Biotech Co Ltd | Treating ige-mediated allergic diseases |
| US11857623B2 (en) * | 2020-08-07 | 2024-01-02 | King Abdulaziz University | Pan-antiallergy vaccine |
| US20260035484A1 (en) * | 2021-10-29 | 2026-02-05 | Longbio Pharma (Suzhou) Co., Ltd. | Isolated antigen binding protein and use thereof |
| CN115873867B (zh) * | 2022-09-28 | 2023-06-23 | 云南省农业科学院农业环境资源研究所 | 一种抗稻瘟病基因Pi69及其编码蛋白与应用 |
| CN120271714A (zh) * | 2022-12-07 | 2025-07-08 | 南开大学 | 一种针对IgE的抗体或其抗原结合片段以及Fc变体 |
| CN118878689B (zh) * | 2024-08-28 | 2025-03-28 | 上海索莱宝生化科技有限公司 | 抗猪IgG抗体及其应用 |
Family Cites Families (35)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4208479A (en) * | 1977-07-14 | 1980-06-17 | Syva Company | Label modified immunoassays |
| JPS5668615A (en) * | 1979-11-09 | 1981-06-09 | Eisai Co Ltd | Ricin-containing agent for immunological enhancement |
| US4980286A (en) | 1985-07-05 | 1990-12-25 | Whitehead Institute For Biomedical Research | In vivo introduction and expression of foreign genetic material in epithelial cells |
| GB8616166D0 (en) * | 1986-07-02 | 1986-08-06 | Research Corp Ltd | Polypeptide competitor |
| JPS63225397A (ja) | 1986-10-03 | 1988-09-20 | Dainippon Pharmaceut Co Ltd | 抗アレルギー作用を有する新規ペプチド |
| GB8913737D0 (en) | 1989-06-15 | 1989-08-02 | Univ Birmingham | A novel anti-allergy treatment |
| US5436146A (en) | 1989-09-07 | 1995-07-25 | The Trustees Of Princeton University | Helper-free stocks of recombinant adeno-associated virus vectors |
| WO1992006180A1 (en) | 1990-10-01 | 1992-04-16 | University Of Connecticut | Targeting viruses and cells for selective internalization by cells |
| CA2103064A1 (en) | 1991-05-14 | 1992-11-15 | George Y. Wu | Targeted delivery of genes encoding immunogenic proteins |
| AU657345B2 (en) | 1991-05-24 | 1995-03-09 | Northwestern University | Method of using substance P to treat allergy |
| WO1992022635A1 (en) | 1991-06-05 | 1992-12-23 | University Of Connecticut | Targeted delivery of genes encoding secretory proteins |
| US5965709A (en) * | 1991-08-14 | 1999-10-12 | Genentech, Inc. | IgE antagonists |
| SE9102808L (sv) | 1991-09-26 | 1993-03-27 | Lars T Hellman Inst F Immunolo | Vaccin, foer humant bruk, vars avsedda effekt aer att lindra symptomen eller foerhindra uppkomsten av ige-medierade allergiska reaktioner |
| WO1993014188A1 (en) | 1992-01-17 | 1993-07-22 | The Regents Of The University Of Michigan | Targeted virus |
| WO1993020221A1 (en) | 1992-04-03 | 1993-10-14 | Young Alexander T | Gene therapy using targeted viral vectors |
| WO1994008598A1 (en) | 1992-10-09 | 1994-04-28 | Advanced Tissue Sciences, Inc. | Liver reserve cells |
| JPH08503855A (ja) | 1992-12-03 | 1996-04-30 | ジェンザイム・コーポレイション | 嚢胞性線維症に対する遺伝子治療 |
| GB9324013D0 (en) * | 1993-11-22 | 1994-01-12 | 3I Res Expl Ltd | Polypeptides |
| FR2715304B1 (fr) * | 1994-01-26 | 1996-04-26 | Merieux Serums Vaccins Pasteur | Vaccin anti-allergique. |
| US5629415A (en) * | 1994-11-09 | 1997-05-13 | Merck & Co., Inc. | DNA encoding canine immunoglobulin E |
| JPH09169795A (ja) * | 1995-12-22 | 1997-06-30 | Hitachi Chem Co Ltd | イヌ免疫グロブリンｅペプチド断片、それをコードするｄｎａ、そのｄｎａを含む組換えベクター、その組換えベクターを含む形質転換体及び抗イヌ免疫グロブリンｅ抗体の製造法 |
| WO1997030156A2 (en) | 1996-02-14 | 1997-08-21 | Idexx Laboratories, Inc. | NUCLEOTIDES AND PEPTIDES CORRESPONDING TO THE CANINE IgE HEAVY CHAIN CONSTANT REGION AND RELATED METHODS |
| CN1174998C (zh) | 1996-03-01 | 2004-11-10 | 诺瓦提斯公司 | 用于预防和治疗过敏的肽免疫原 |
| ES2165626T3 (es) | 1996-08-30 | 2002-03-16 | Exxonmobil Chem Patents Inc | Reactor y procedimiento en lecho fluidizado. |
| WO1998024808A2 (en) * | 1996-12-06 | 1998-06-11 | THE UNITED STATES OF AMERICA represented by THE SECRETARY DEPARTMENT OF HEALTH & HUMAN SERVICES, THE NATIONAL INSTITUTES OF HEALTH | INHIBITION OF IgE-MEDIATED ALLERGIES BY A HUMAN IgE-DERIVED OLIGOPEPTIDE |
| ES2234180T3 (es) * | 1998-04-09 | 2005-06-16 | Idexx Laboratories, Inc. | Proteinas de fijacion especifica para el tratamiento de la alergia canina. |
| US6734287B1 (en) * | 1998-04-09 | 2004-05-11 | Idexx Laboratories, Inc. | Specific binding proteins for treating canine allergy |
| TWI229679B (en) * | 1998-06-20 | 2005-03-21 | United Biomedical Inc | Artificial T helper cell epitopes as immune stimulators for synthetic peptide immunogens |
| TWI227241B (en) * | 1998-06-20 | 2005-02-01 | United Biomedical Inc | IgE-CH3 domain antigen peptide, peptide conjugate containing the same, and pharmaceutical composition for treating allergies containing the peptide conjugate |
| PL198236B1 (pl) * | 1998-06-24 | 2008-06-30 | Alk Abello As | Sposób określania działania swoistego szczepienia przeciw alergii oraz sposób określania stanu immunologicznego osobnika alergicznego |
| GB9822763D0 (en) * | 1998-10-20 | 1998-12-16 | Univ Sheffield | Immunoglobin variant |
| US6913749B2 (en) * | 1998-11-02 | 2005-07-05 | Resistentia Pharmaceuticals Ab | Immunogenic polypeptides for inducing anti-self IgE responses |
| CN1202125C (zh) * | 1998-11-12 | 2005-05-18 | 卫生部上海生物制品研究所 | 肽免疫原、用其制成的治疗变态反应的疫苗及其制备方法 |
| EP1195161A3 (en) * | 2000-08-30 | 2002-07-24 | Pfizer Products Inc. | Anti-IgE vaccines |
| JP2003047482A (ja) | 2001-05-22 | 2003-02-18 | Pfizer Prod Inc | 非アナフィラキシー誘発性ＩｇＥワクチン |
-
2001
- 2001-08-24 EP EP01307247A patent/EP1195161A3/en not_active Withdrawn
- 2001-08-24 EP EP08156884A patent/EP1967205B1/en not_active Expired - Lifetime
- 2001-08-24 EP EP08156885A patent/EP1967206B1/en not_active Expired - Lifetime
- 2001-08-24 EP EP10183753A patent/EP2361635A3/en not_active Withdrawn
- 2001-08-24 EP EP09154655A patent/EP2065052A3/en not_active Ceased
- 2001-08-24 US US09/938,700 patent/US6887472B2/en not_active Expired - Fee Related
- 2001-08-28 CA CA2674837A patent/CA2674837C/en not_active Expired - Fee Related
- 2001-08-28 CA CA002356124A patent/CA2356124A1/en not_active Abandoned
- 2001-08-28 CA CA2674838A patent/CA2674838C/en not_active Expired - Fee Related
- 2001-08-28 CA CA2674885A patent/CA2674885C/en not_active Expired - Fee Related
- 2001-08-28 CA CA002674888A patent/CA2674888A1/en not_active Abandoned
- 2001-08-30 JP JP2001261760A patent/JP2002281984A/ja active Pending
-
2004
- 2004-01-05 US US10/751,743 patent/US20040146504A1/en not_active Abandoned
- 2004-08-25 JP JP2004244935A patent/JP2005043374A/ja active Pending
- 2004-11-24 JP JP2004338711A patent/JP2005102701A/ja active Pending
-
2005
- 2005-08-04 US US11/196,897 patent/US7897151B2/en not_active Expired - Fee Related
-
2009
- 2009-11-24 US US12/624,566 patent/US8273356B2/en not_active Expired - Fee Related
-
2012
- 2012-03-30 JP JP2012080895A patent/JP2012161322A/ja active Pending
- 2012-08-22 US US13/591,288 patent/US20120321651A1/en not_active Abandoned
- 2012-10-22 JP JP2012232974A patent/JP2013056904A/ja active Pending
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2005102701A5 (enExample) | ||
| US10654913B2 (en) | Fibronectin type III domain based scaffold compositions, methods and uses | |
| AU2010213892B2 (en) | Fibronectin type III domain based scaffold compositions, methods and uses | |
| US8415291B2 (en) | Anti-TNF alpha fibronectin type III domain based scaffold compositions, methods and uses | |
| JP2015164424A5 (enExample) | ||
| JP2009507474A5 (enExample) | ||
| RU2009119925A (ru) | Il-18 вакцина для лечения различных воспалительных состояний | |
| JP2005502327A5 (enExample) | ||
| RU2007127921A (ru) | Вакцины и их применение | |
| RU2007108037A (ru) | Фармацевтическая композиция для лечения гепатита с на основе неинфекционных псевдовирионов вируса гепатита с | |
| HK1160891B (en) | Fibronectin type iii domain based scaffold compositions, methods and uses |